M
Maureen Hillhouse
Researcher at University of California, Los Angeles
Publications - 67
Citations - 3370
Maureen Hillhouse is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Buprenorphine & Naloxone. The author has an hindex of 31, co-authored 66 publications receiving 2979 citations. Previous affiliations of Maureen Hillhouse include Semel Institute for Neuroscience and Human Behavior.
Papers
More filters
Journal ArticleDOI
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.
Yih-Ing Hser,Andrew J. Saxon,David Huang,Al Hasson,Christie Thomas,Maureen Hillhouse,Petra Jacobs,Cheryl Teruya,Paul McLaughlin,Katharina Wiest,Allan Cohen,Walter Ling +11 more
TL;DR: This paper examined patient and medication characteristics associated with retention and continued illicit opioid use in methadone versus buprenorphine/naloxone (BUP) treatment for opioid dependence.
Journal ArticleDOI
A multi-center randomized trial of buprenorphine–naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network
Walter Ling,Leslie Amass,Steve Shoptaw,Jeffrey J. Annon,Maureen Hillhouse,Dean Babcock,Greg Brigham,Judy Harrer,Malcolm S. Reid,Joan A. Muir,Betty J. Buchan,Debbie Orr,George E. Woody,Jonathan Krejci,Douglas M. Ziedonis +14 more
TL;DR: The benefits of bup-nx for opioid detoxification are supported and illustrate important ways in which clinical research can be conducted in community treatment programs.
Journal ArticleDOI
Comparative Profiles of Men and Women with Opioid Dependence: Results from a National Multisite Effectiveness Trial
Sudie E. Back,Rebecca L. Payne,Amy H. Wahlquist,Rickey E. Carter,Zachary Stroud,Louise Haynes,Maureen Hillhouse,Kathleen T. Brady,Walter Ling +8 more
TL;DR: Important gender differences in the clinical profiles of opioid-dependent individuals were observed with regard to substance use severity, craving, medical conditions, and impairment in associated areas of functioning.
Journal ArticleDOI
Drug treatment and 12-step program participation: the additive effects of integrated recovery activities.
TL;DR: There is an additive effect of these recovery activities in that those who participate concurrently in both drug treatment and 12-step programs had higher rates of abstinence than those who participated only in treatment or in 12- step programs.
Journal ArticleDOI
Prescription opioid abuse, pain and addiction: clinical issues and implications
TL;DR: The article discusses the need to identify methods for minimising risks and negative consequences associated with opioid analgesics and poses research directions, including the development of abuse-deterrent opioid formulations, genetic risk factors for opioid dependence and opioid-induced hyperalgesia as a potential target for medication therapy.